Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma Via a Comprehensive Analysis

Overview

Journal Bioengineering (Basel)

Date 2022 Jul 25

PMID 35877357

Authors

Shujing Li

Xianggang Wang

Qingqing Wang

Kaixin Ding

Xin Chen

Yun Zhao

Yu Gao

Yuanyuan Wang

Affiliations

Soon will be listed here.

Abstract

Kidney renal clear cell carcinoma (KIRC) is one of the most prevalent and deadly types of renal cancer in adults. Recent research has identified circadian genes as being involved in the development and progression of KIRC by altering their expression. This study aimed to identify circadian genes that are differentially expressed in KIRC and assess their role in KIRC progression. In KIRC, there were 553 differentially expressed rhythm genes (DERGs), with 300 up-regulated and 253 down-regulated DERGs. Functional enrichment analyses showed that DERGs were greatly enriched in the circadian rhythm and immune response pathways. Survival analyses indicated that higher expression levels of CSNK1E were related to shorter overall survival of KIRC patients, whereas lower expression levels of GNA11, KLF9, and THRAP3 were associated with shorter overall survival of KIRC patients. Through cell assay verification, the mRNA level of CSNK1E was significantly up-regulated, whereas the mRNA levels of GNA11, KLF9, and THRAP3 were dramatically down-regulated in KIRC cells, which were consistent with the bioinformatics analysis of KIRC patient samples. Age, grade, stage, TM classification, and CSNK1E expression were all shown to be high-risk variables, whereas GNA11, KLF9, and THRAP3 expression were found to be low-risk factors in univariate Cox analyses. Multivariate Cox analyses showed that CSNK1E and KLF9 were also independently related to overall survival. Immune infiltration analysis indicated that the proportion of immune cells varied greatly between KIRC tissues and normal tissue, whereas CSNK1E, GNA11, KLF9, and THRAP3 expression levels were substantially linked with the infiltration abundance of immune cells and immunological biomarkers. Moreover, interaction networks between CSNK1E/GNA11/KLF9/THRAP3 and immune genes were constructed to explore the stream connections. The findings could help us better understand the molecular mechanisms of KIRC progression, and CSNK1E/GNA11/KLF9/THRAP3 might be used as molecular targets for chronotherapy in KIRC patients in the near future.

Citing Articles

Pan-cancer and single-cell analysis reveal THRAP3 as a prognostic and immunological biomarker for multiple cancer types.

Wang Y, Ma C, Yang X, Zhang N, Sun Z Front Genet. 2024; 15:1277541.

PMID: 38333620 PMC: 10850301. DOI: 10.3389/fgene.2024.1277541.

Circadian clock-related genome-wide mendelian randomization identifies putatively genes for ulcerative colitis and its comorbidity.

Huang M, Wu Y, Li Y, Chen X, Feng J, Li Z BMC Genomics. 2024; 25(1):130.

PMID: 38302916 PMC: 10832088. DOI: 10.1186/s12864-024-10003-z.

Krüppel-like Factor-9 and Krüppel-like Factor-13: Highly Related, Multi-Functional, Transcriptional Repressors and Activators of Oncogenesis.

Simmen F, Alhallak I, Simmen R Cancers (Basel). 2023; 15(23).

PMID: 38067370 PMC: 10705314. DOI: 10.3390/cancers15235667.

Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration.

Wang Q, Zhou S, Hu X, Wang X, Wu X, Huai Z Life (Basel). 2023; 13(5).

PMID: 37240761 PMC: 10221058. DOI: 10.3390/life13051116.

Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma.

Shang B, Wang R, Qiao H, Zhao X, Wang L, Sui S PeerJ. 2023; 11:e15340.

PMID: 37193028 PMC: 10183172. DOI: 10.7717/peerj.15340.

References

Li M, Chen Z, Jiang T, Yang X, Du Y, Liang J . Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer. J Cancer. 2021; 12(9):2582-2597. PMC: 8040717. DOI: 10.7150/jca.52454. View

Huisman S, Ahmadi A, IJzermans J, Verhoef C, van der Horst G, de Bruin R . Disruption of clock gene expression in human colorectal liver metastases. Tumour Biol. 2016; 37(10):13973-13981. PMC: 5097083. DOI: 10.1007/s13277-016-5231-7. View

Jager M, Shields C, Cebulla C, Abdel-Rahman M, Grossniklaus H, Stern M . Uveal melanoma. Nat Rev Dis Primers. 2020; 6(1):24. DOI: 10.1038/s41572-020-0158-0. View

Kiessling S, Beaulieu-Laroche L, Blum I, Landgraf D, Welsh D, Storch K . Enhancing circadian clock function in cancer cells inhibits tumor growth. BMC Biol. 2017; 15(1):13. PMC: 5310078. DOI: 10.1186/s12915-017-0349-7. View

Zhang F, Sun H, Zhang S, Yang X, Zhang G, Su T . Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling. Oncol Res. 2016; 25(5):709-719. PMC: 7841129. DOI: 10.3727/096504016X14772331883976. View

Moller-Levet C, Archer S, Bucca G, Laing E, Slak A, Kabiljo R . Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A. 2013; 110(12):E1132-41. PMC: 3607048. DOI: 10.1073/pnas.1217154110. View

Dulong S, Ballesta A, Okyar A, Levi F . Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling. Mol Cancer Ther. 2015; 14(9):2154-64. DOI: 10.1158/1535-7163.MCT-15-0129. View

Yuan P, Yang T, Mu J, Zhao J, Yang Y, Yan Z . Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509]. Cancer Lett. 2021; 521:322-323. DOI: 10.1016/j.canlet.2021.09.006. View

Li S, Shui K, Zhang Y, Lv Y, Deng W, Ullah S . CGDB: a database of circadian genes in eukaryotes. Nucleic Acids Res. 2016; 45(D1):D397-D403. PMC: 5210527. DOI: 10.1093/nar/gkw1028. View

10.

Zhanfeng N, Yanhui L, Zhou F, Shaocai H, Guangxing L, Hechun X . Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo. Oncotarget. 2015; 6(12):9951-8. PMC: 4496409. DOI: 10.18632/oncotarget.3179. View

11.

Tang Q, Cheng B, Xie M, Chen Y, Zhao J, Zhou X . Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma. Cancer Res. 2016; 77(2):532-544. DOI: 10.1158/0008-5472.CAN-16-1322. View

12.

Hassan S, Schmithals C, von Harten M, Piiper A, Korf H, von Gall C . Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model. Int J Cancer. 2020; 148(1):226-237. DOI: 10.1002/ijc.33228. View

13.

Wan B, Liu B, Huang Y, Yu G, Lv C . Prognostic value of immune-related genes in clear cell renal cell carcinoma. Aging (Albany NY). 2019; 11(23):11474-11489. PMC: 6932908. DOI: 10.18632/aging.102548. View

14.

Chen P, Hsu W, Chang A, Tan Z, Lan Z, Zhou A . Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Discov. 2020; 10(3):371-381. PMC: 7058515. DOI: 10.1158/2159-8290.CD-19-0400. View

15.

Varghese R, Liang Y, Guan T, Franck C, Kelly D, Sheng Z . Survival kinase genes present prognostic significance in glioblastoma. Oncotarget. 2016; 7(15):20140-51. PMC: 4991443. DOI: 10.18632/oncotarget.7917. View

16.

Knippschild U, Gocht A, Wolff S, Huber N, Lohler J, Stoter M . The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal. 2005; 17(6):675-89. DOI: 10.1016/j.cellsig.2004.12.011. View

17.

Li B, Yang X, Li J, Yang Y, Yan Z, Zhang H . [Elevated expression of CLOCK is associated with poor prognosis in hepatocellular carcinoma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018; 34(2):163-168. View

18.

Zhou L, Luo Z, Li Z, Huang Q . Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma. Aging (Albany NY). 2020; 12(14):14620-14632. PMC: 7425457. DOI: 10.18632/aging.103509. View

19.

Ye Y, Xiang Y, Ozguc F, Kim Y, Liu C, Park P . The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy. Cell Syst. 2018; 6(3):314-328.e2. PMC: 6056007. DOI: 10.1016/j.cels.2018.01.013. View

20.

Bollinger T, Leutz A, Leliavski A, Skrum L, Kovac J, Bonacina L . Circadian clocks in mouse and human CD4+ T cells. PLoS One. 2012; 6(12):e29801. PMC: 3247291. DOI: 10.1371/journal.pone.0029801. View